Solid foundation for higher move. Technical indicators continue positive. Currently undergoing trials for novel vascular disrupting cancer drug following US IND approvals.Recent $1 million licencing payment from big Euro pharma co.
BNO Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held